High-resolution molecular imaging of the retina

In vivo Imaging of the Human Retina at the Molecular Level

NIH-funded research Doheny Eye Institute · NIH-11290385

A new high-resolution eye imaging method that looks at tiny molecular signals in the retina to spot early changes linked to aging and macular degeneration.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDoheny Eye Institute NIH-funded
Lab location1 site (Pasadena, UNITED STATES)
Project IDNIH-11290385 on NIH RePORTER

What this research studies

This project combines fluorescence lifetime imaging (which measures how long natural eye molecules glow) with adaptive optics to create cellular-level pictures of the retina. The team will build an AO-enhanced FLIO system on an AOSLO platform to achieve roughly 2 μm lateral resolution over a substantially larger field than current instruments. They will add advanced image-processing to separate overlapping color and lifetime signals and map metabolic and oxidative changes in retinal layers and the retinal pigment epithelium. The instrument will be tested and refined on human eyes to produce repeatable molecular maps that could guide future diagnostics.

Who could benefit from this research

Good fit: Adults with age-related macular degeneration, other retinal disorders, or age-related vision changes who can travel to the imaging center and tolerate retinal imaging are ideal candidates.

Not a fit: People who cannot sit still for eye imaging, have active eye infections, very small pupils that cannot be dilated, or are medically unable to travel to Pasadena may not benefit or be eligible.

Why it matters

Potential benefit: Could allow earlier and more precise detection of metabolic changes in the retina, improving diagnosis and monitoring of age-related macular degeneration and other retinal conditions.

How similar studies have performed: FLIO and AOSLO have each shown promise in retinal imaging, but combining adaptive optics with fluorescence lifetime imaging at cellular resolution is a novel advancement.

Where this research is happening

Pasadena, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions CNS DiseasesCNS disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.